Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill K Slack

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Biology & Therapy|November 13, 2009
The promise of antiangiogenic therapy for ovarian cancerAmir A Jazaeri, Jill K Slack-Davis
Journal of Cellular Biochemistry|December 23, 2003
Emerging views of integrin signaling: implications for prostate cancerJill K Slack-Davis, J Thomas Parsons
Molecular and Cellular Biology|August 9, 2002
Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexesScott T Eblen, Jill K Slack, Michael J Weber, et al.
Plos One|March 14, 2015
Decreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1John Nakayama, Timothy A Raines, Kevin R Lynch, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2014
VCAM-1 on peritoneum and α4β1 integrin in endometrium and their implications in endometriosisAmy K Schutt, Kristen A Atkins, Jill K Slack-Davis, et al.
Cancer Research|February 12, 2009
Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasisJill K Slack-Davis, Kristen A Atkins, Christine Harrer, et al.
Science (New York, N.Y.)|June 1, 2002
Integrin connections map: to infinity and beyondKaren H Martin, Jill K Slack, Scott A Boerner, et al.
Molecular Cancer Therapeutics|August 13, 2009
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate modelJill K Slack-Davis, E Daniel Hershey, Dan Theodorescu, et al.
Molecular Cancer Therapeutics|February 3, 2016
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to CarboplatinBarbara Dziegielewska, Eli V Casarez, Wesley Z Yang, et al.
Molecular and Cellular Biology|March 3, 2004
Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesionScott T Eblen, Jill K Slack-Davis, Adel Tarcsafalvi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Biology & Therapy|November 13, 2009
The promise of antiangiogenic therapy for ovarian cancerAmir A Jazaeri, Jill K Slack-Davis
Journal of Cellular Biochemistry|December 23, 2003
Emerging views of integrin signaling: implications for prostate cancerJill K Slack-Davis, J Thomas Parsons
Molecular and Cellular Biology|August 9, 2002
Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexesScott T Eblen, Jill K Slack, Michael J Weber, et al.
Plos One|March 14, 2015
Decreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1John Nakayama, Timothy A Raines, Kevin R Lynch, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2014
VCAM-1 on peritoneum and α4β1 integrin in endometrium and their implications in endometriosisAmy K Schutt, Kristen A Atkins, Jill K Slack-Davis, et al.
Cancer Research|February 12, 2009
Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasisJill K Slack-Davis, Kristen A Atkins, Christine Harrer, et al.
Science (New York, N.Y.)|June 1, 2002
Integrin connections map: to infinity and beyondKaren H Martin, Jill K Slack, Scott A Boerner, et al.
Molecular Cancer Therapeutics|August 13, 2009
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate modelJill K Slack-Davis, E Daniel Hershey, Dan Theodorescu, et al.
Molecular Cancer Therapeutics|February 3, 2016
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to CarboplatinBarbara Dziegielewska, Eli V Casarez, Wesley Z Yang, et al.
Molecular and Cellular Biology|March 3, 2004
Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesionScott T Eblen, Jill K Slack-Davis, Adel Tarcsafalvi, et al.
Pageof 3